Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAG-7 relapse prevention after ECT in major depression
2008-003877-42Phase 4Completed
- Sponsor
- Danish University Antidepressant Group
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram and nortriptyline in major depressive disorder (MDD) (4 arms), sponsored by Danish University Antidepressant Group. Primary endpoint: Relapse within 6 months after final ECT. Started Oct 2008; status: completed.
02
Drugs
escitalopramnortriptyline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-003877-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003877-42.